Could a tiny device free people with type 1 diabetes from daily shots?
NCT ID NCT06408311
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This early-stage trial tests a small device placed under the skin that contains insulin-producing cells. The goal is to see if it is safe and tolerable for people with type 1 diabetes who already receive standard islet transplants. Only 10 participants are enrolled, and the main focus is on safety, not yet on how well it controls blood sugar.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
macro-encapsulated human primary islets
What this could lead to
If successful, this could lead to a safer way to transplant insulin-producing cells without lifelong immune suppression, potentially improving blood sugar control.
What could go wrong
This is a very early Phase 1 trial with only 10 participants, so safety and feasibility are the main goals. The device may not work as hoped, and long-term benefits are uncertain.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIABETES MELLITUS, TYPE 1 are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
McGill University Health Centre
Montreal, Quebec, H4A 3J1, Canada
-
UHN
Toronto, Ontario, M5G 2C4, Canada